Lecture, Comparative Indo-European Linguistics (CIEL) Seminars

Leiden chemists have developed a new technique with which they can determine the role of kinases – a group of proteins – in a living cell. This technique makes it easier to find new drug targets for diseases such as cancer and rheumatoid arthritis. The team published the findings in the journal Nature…

Bacteria carry countless hidden treasures in their DNA: fragments that could hold the key to new medicines. But how do you pick out the most promising ones from millions of options? ‘Look at the switches that turn genes on and off,’ says molecular biologist Gilles van Wezel.

There is a link in adolescents between brain connections and impulsiveness. Leiden researchers have discovered that these connections also predict which adolescents will make more impulsive choices two years further on.

Covid year 2021 might have felt somewhat less strange than the year before, but the virus still left its mark on University life and our students and staff. Fortunately there was also room for research, visiting dignitaries and in-person classes. And our social media accounts weren’t only about covid…

Historical figures such as Columbus have returned to the centre of public debate. Much remains to be discovered about his legacy and current impact on our society. A new study shows the ecological footprint that the arrival of Europeans left in the Caribbean islands.

Plant biologist Pingtao Ding, assistant professor at the Institute of Biology Leiden (IBL), has received a 2.4 million European grant from the European Research Council (ERC). This ERC Starting Grant for promising young researchers allows him to unravel the molecular mechanisms by which plants resist…

Laura Heitman has been awarded a VIDI grant for her innovative drug research. Heitman strives to optimize a drug’s binding kinetics at its target in order to ultimately fight diseases effectively. She even pleads for a paradigm shift in drug discovery.

This summer postdoctoral researcher Mónica Varela from the Institute of Biology Leiden was awarded a Veni grant from the Dutch Research Council (NWO). Six questions about her project and hopes for the future.

In a survey held last year by the publication Elsevier, Leiden's Computer Science programme was voted by students as the best university programme of its kind in the Netherlands. And the Rotterdam Economics programme was voted the best in its field. Leiden University now offers a combined study based…

Researchers need to work in specialized environments when they work with dangerous bacteria and viruses. These microbes spread easily, so only in labs with a high biosafety levels they can be studied. Unfortunately, to look at the microbes properly, expensive microscopes are needed that are not always…

The research group headed by Leiden chemist Marc Koper has discovered a catalyst that minimizes the production of chlorine gas during salt water electrolysis. The invention can enable the direct production of hydrogen from seawater. The article has been published in the Journal of the American Chemical…

How do you know if a drug will actually work? The Leiden-based spin-off Omivera is developing a new technology that could provide clearer answers. The young company received a seed investment from the investment fund UNIIQ to support its development.

Media in the Netherlands and abroad reported extensively about the drug research led by Leiden chemist Mario van der Stelt. In this research, Van der Stelt shows which unwanted side-effects a French drug candidate has.

Why have some European countries responded faster to the coronavirus outbreak than others? While in some countries the lockdown had already been declared when relatively few cases were known, others did not take action until thousands of people were already infected and hundreds were already dead. What…

Breast cancer (BC) is a clinically and biologically heterogeneous disease.

'It gave our team a big boost to hear that our work was valuable,' says medical chemist Elmer Maurits about the moment they won the Venture Challenge. With their company Iprotics, they want to develop a drug that can better treat patients with autoimmune diseases and blood cancers. 25,000 euros of prize…

Earning some quick money by drug trafficking, committing an act of violence or almost collapsing under performance pressure. In the four-part NeurolabNL Young vodcast young people talk openly with neuroscientists about high-risk behaviour and performance pressure. How did they find their way back?

The D&I Expertise Office is in close contact with various student and staff networks regarding diversity and inclusion.

Do you recall all those drugs that were hastily proposed as potential treatments for COVID-19? In the event of a future pandemic, the goal is to offer an effective treatment more quickly and efficiently. To achieve this, a team led by Coen van Hasselt is developing a platform that can speed up the process…

Young people spend a lot of their time online. Even so, we still know very little about how this intensive use of social media influences their development. Brain researcher and Spinoza Prize winner Eveline Crone from Leiden University and media psychologist Elly Konijn (VU) describes what the research…

Conference

The opportunity to explore a new, exciting research topic. That is how Lennart Schada von Borzyskowski describes his successful application for the NWO XS grant. It comprises 50,000 euros, which the researcher from the Institute of Biology Leiden (IBL) will spend on investigating a more sustainable…

Lecture

According to the LUMC, patients experience 30% fewer serious side effects when medication doses are tailored to their DNA.

PhD defence

The fact that scientists are increasingly better able to access molecular cell and tissue data also brings with it a new challenge: how can scientists find the information they need for research among the vast amount of data available?

Researcher Daan van der Vliet, together with colleagues from the Netherlands Institute for Neuroscience, Leiden University and Utrecht University, has discovered an important mechanism that may be linked to severe cases of multiple sclerosis (MS): the brain contains large numbers of abnormal immune…

Public funding for fundamental research is essential for innovation and the development of new medicines. This is demonstrated by Professor Science Based Business Simcha Jong and his colleague Hsini Huang after studying US federal funding restrictions for stem cell research under President George W.…

Professor Wolff discusses the EU migration policy on Global Europe.

Lecture and panel

Study information, Student for a Day

Study information, Experience Day

A consortium of research groups, including that of LACDR professor Erik Danen, will use an NWO Perspective grant of nearly five million euros to build a universal standard for organ-on-chip models. They aim to stimulate the application of these chips in the biomedical and pharmaceutical industry. Danen…

Before patients can take a pill, scientists often spend years in the lab developing and testing a candidate drug. That often includes experiments with laboratory animals. As head of the rodent facility, Ilze Bot and her colleagues ensure that these experiments are conducted in an ethically responsible…

A Preventive Intervention Team that investigates children with behavioural problems and trains their social skills in order to prevent school dropout and other, more serious problems. This is a strategy that Leiden University and the municipality of Amsterdam have been using for several years already,…

Lecture, Sign Languages & Deaf People

Edith Schippers, Minister of Health, will be investing six million euros over the coming four years to boost research on new antibiotics. The programme will be set up by several different parties, including the Leiden Centre for Antimicrobial Research.

André Leliveld has won a grant of 100,000 euros within the Comenius Senior Fellow programme for the project ‘Learning globally, acting locally: co-creation of an international multidisciplinary online learning environment around Frugal Innovation'. André is academic coordinator of the Leiden-Delft-Erasmus…

On Sept. 29, Lara Wierenga, together with graphic designer Dirma Janse, presented their new book Atlas of our Brain. In the presence of fellow scientists and other interested parties, they shared some of the stunning illustrations and mind-boggling facts that can be found in the book.

Leiden biotech startup Azafaros has successfully completed a funding round, raising 25 million euros of investments for developing treatments of rare metabolic disorders. The company holds exclusive license to a library of novel patented compounds discovered by experts from Leiden University.